The Oncology Institute promoted Rakesh Panda to CIO and Nolan Mariano to CPO, enhancing technology and culture in cancer care.
Quiver AI Summary
The Oncology Institute, Inc. has announced the promotions of Rakesh Panda to Chief Information Officer and Nolan Mariano to Chief People Officer, effective January 9, 2026. These appointments reflect the company’s commitment to advancing value-based cancer care through enhanced technology and a strong organizational culture. Rakesh Panda brings over 25 years of experience in IT and digital transformation, and he will lead TOI's technology strategy, including AI initiatives and data security. Nolan Mariano, who has 18 years of experience in People Operations, will manage HR functions at TOI after joining the company in 2022. CEO Dr. Daniel Virnich expressed his enthusiasm for promoting these internal leaders to support TOI’s growth and dedicated cancer care mission.
Potential Positives
- Promoting Rakesh Panda to Chief Information Officer strengthens TOI’s commitment to advancing technology-enabled care delivery, highlighting the company's focus on innovation in oncology.
- Nolan Mariano's appointment as Chief People Officer emphasizes TOI's dedication to developing a strong organizational culture and enhancing HR practices, which can improve employee satisfaction and retention.
- Both promotions reflect TOI's strategy of fostering internal talent in leadership roles, indicating a stable and growth-oriented company culture as it continues to expand its operations.
Potential Negatives
- The press release does not disclose any measurable outcomes or specific strategies associated with the promotions, which could lead to uncertainty about the effectiveness of the new leadership in addressing the company's challenges.
- There is no mention of how the promotions will specifically impact the company's growth or operational efficiency, raising concerns about the clarity of the organization's direction.
- While the company highlights internal promotions, it does not address any possible challenges or issues within the current leadership that necessitated these changes, potentially leaving stakeholders questioning the stability and effectiveness of the management team.
FAQ
Who has been appointed as Chief Information Officer at The Oncology Institute?
Rakesh Panda has been appointed Chief Information Officer at The Oncology Institute.
Who is the new Chief People Officer at The Oncology Institute?
Nolan Mariano has been appointed Chief People Officer at The Oncology Institute.
What is Rakesh Panda's experience in the tech industry?
Rakesh Panda has over 25 years of experience in IT, digital transformation, and cybersecurity.
What will Nolan Mariano oversee as Chief People Officer?
Nolan Mariano will oversee HR Operations, Total Rewards, Learning and Development, and Talent Acquisition.
What is the mission of The Oncology Institute?
The Oncology Institute aims to provide leading value-based cancer care in community settings.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$TOI Insider Trading Activity
$TOI insiders have traded $TOI stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $TOI stock by insiders over the last 6 months:
- GROWTH I L.P. M33 has made 0 purchases and 2 sales selling 6,700,000 shares for an estimated $20,702,999.
- MARK L PACALA has made 0 purchases and 3 sales selling 50,000 shares for an estimated $200,000.
- BRAD HIVELY has made 0 purchases and 2 sales selling 33,554 shares for an estimated $132,388.
- ROBERT ROSS CARTER (Chief Financial Officer) sold 247 shares for an estimated $879
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$TOI Revenue
$TOI had revenues of $136.6M in Q3 2025. This is an increase of 36.7% from the same period in the prior year.
You can track TOI financials on Quiver Quantitative's TOI stock page.
$TOI Hedge Fund Activity
We have seen 68 institutional investors add shares of $TOI stock to their portfolio, and 30 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TIFF ADVISORY SERVICES, LLC removed 2,777,837 shares (-76.4%) from their portfolio in Q3 2025, for an estimated $9,694,651
- CENTERBOOK PARTNERS LP added 1,988,751 shares (+277.8%) to their portfolio in Q3 2025, for an estimated $6,940,740
- KANEN WEALTH MANAGEMENT LLC added 1,842,101 shares (+inf%) to their portfolio in Q3 2025, for an estimated $6,428,932
- MARSHALL WACE, LLP removed 1,451,782 shares (-98.3%) from their portfolio in Q3 2025, for an estimated $5,066,719
- UBS GROUP AG added 635,489 shares (+151.2%) to their portfolio in Q3 2025, for an estimated $2,217,856
- MILLENNIUM MANAGEMENT LLC added 545,992 shares (+134.8%) to their portfolio in Q3 2025, for an estimated $1,905,512
- GOLDMAN SACHS GROUP INC added 527,011 shares (+340.8%) to their portfolio in Q3 2025, for an estimated $1,839,268
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$TOI Analyst Ratings
Wall Street analysts have issued reports on $TOI in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 11/25/2025
- BTIG issued a "Buy" rating on 10/21/2025
To track analyst ratings and price targets for $TOI, check out Quiver Quantitative's $TOI forecast page.
$TOI Price Targets
Multiple analysts have issued price targets for $TOI recently. We have seen 3 analysts offer price targets for $TOI in the last 6 months, with a median target of $6.0.
Here are some recent targets:
- Matthew Shea from Needham set a target price of $5.0 on 11/25/2025
- David Larsen from BTIG set a target price of $7.0 on 10/21/2025
- Yuan Zhi from B. Riley Securities set a target price of $6.0 on 07/16/2025
Full Release
Rakesh Panda appointed Chief Information Officer
Nolan Mariano appointed Chief People Officer
CERRITOS, Calif., Jan. 09, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) announced today the promotions of Rakesh Panda to Chief Information Officer and Nolan Mariano to Chief People Officer. These promotions reinforce TOI’s continued focus on leading the way in value-based cancer care through further development of our technology-enabled care delivery platform as well as strengthening our mission-oriented culture supported by strong leadership.
Rakesh Panda has more than 25 years of experience across IT, digital transformation, cybersecurity, and enterprise software development, including leadership roles at Cisco and Infosys. Mr. Panda will continue to guide TOI’s technology strategy, including AI-enablement efforts and enterprise-level data privacy and security practices. Nolan Mariano has 18 years of experience in People Operations and organizational leadership across several industries. Mr. Mariano joined TOI in 2022 and, as Chief People Officer, will oversee HR Operations, Total Rewards, Learning and Development, and Talent Acquisition functions.
Dr. Daniel Virnich, Chief Executive Officer at TOI, commented, “I'm extremely pleased to promote two strong internal leaders into key roles at TOI as we continue to experience rapid growth and new ways of driving world-class community-based cancer care for our patients and payor partners.”
About The Oncology Institute
Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better.
Contacts
Media
The Oncology Institute, Inc.
[email protected]
Investors
ICR Healthcare
[email protected]
